BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18382120)

  • 21. Reduced volume of the cerebellar vermis in neuroleptic-naive schizophrenia.
    Ichimiya T; Okubo Y; Suhara T; Sudo Y
    Biol Psychiatry; 2001 Jan; 49(1):20-7. PubMed ID: 11163776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
    Galińska B; Szulc A; Tarasów E; Kubas B; Dzienis W; Siergiejczyk L; Czernikiewicz A; Walecki J
    Med Sci Monit; 2007 May; 13 Suppl 1():11-6. PubMed ID: 17507879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identical neural risk factors predict cognitive deficit in dyslexia and schizophrenia.
    Leonard CM; Kuldau JM; Maron L; Ricciuti N; Mahoney B; Bengtson M; DeBose C
    Neuropsychology; 2008 Mar; 22(2):147-58. PubMed ID: 18331156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo neuropathology of cortical changes in elderly persons with schizophrenia.
    Frisoni GB; Prestia A; Adorni A; Rasser PE; Cotelli M; Soricelli A; Bonetti M; Geroldi C; Giannakopoulos P; Thompson PM
    Biol Psychiatry; 2009 Sep; 66(6):578-85. PubMed ID: 19409532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia.
    Bottmer C; Bachmann S; Pantel J; Essig M; Amann M; Schad LR; Magnotta V; Schröder J
    Psychiatry Res; 2005 Dec; 140(3):239-50. PubMed ID: 16288852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebellar and other neurological soft signs in antipsychotic-naïve schizophrenia.
    Varambally S; Venkatasubramanian G; Thirthalli J; Janakiramaiah N; Gangadhar BN
    Acta Psychiatr Scand; 2006 Nov; 114(5):352-6. PubMed ID: 17022795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insight and prefrontal cortex in first-episode Schizophrenia.
    Shad MU; Muddasani S; Prasad K; Sweeney JA; Keshavan MS
    Neuroimage; 2004 Jul; 22(3):1315-20. PubMed ID: 15219603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of cerebellar grey matter in Crus I and II in schizophrenia.
    Kühn S; Romanowski A; Schubert F; Gallinat J
    Brain Struct Funct; 2012 Apr; 217(2):523-9. PubMed ID: 22131119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disorders of cognitive and affective development in cerebellar malformations.
    Tavano A; Grasso R; Gagliardi C; Triulzi F; Bresolin N; Fabbro F; Borgatti R
    Brain; 2007 Oct; 130(Pt 10):2646-60. PubMed ID: 17872929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological soft signs and brain morphology in first-episode schizophrenia.
    Thomann PA; Wüstenberg T; Santos VD; Bachmann S; Essig M; Schröder J
    Psychol Med; 2009 Mar; 39(3):371-9. PubMed ID: 18578894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder.
    De Bellis MD; Kuchibhatla M
    Biol Psychiatry; 2006 Oct; 60(7):697-703. PubMed ID: 16934769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain volume and dysexecutive behavior in schizophrenia.
    Kawada R; Yoshizumi M; Hirao K; Fujiwara H; Miyata J; Shimizu M; Namiki C; Sawamoto N; Fukuyama H; Hayashi T; Murai T
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1255-60. PubMed ID: 19625009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gray matter morphological anomalies in the cerebellar vermis in first-episode schizophrenia patients with cognitive deficits.
    Wang J; Zhou L; Cui C; Liu Z; Lu J
    BMC Psychiatry; 2017 Nov; 17(1):374. PubMed ID: 29166884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prefrontal subregions and dimensions of insight in first-episode schizophrenia--a pilot study.
    Shad MU; Muddasani S; Keshavan MS
    Psychiatry Res; 2006 Jan; 146(1):35-42. PubMed ID: 16361089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficient associative learning in drug-naive first-episode schizophrenia: results obtained using a new visual within-subjects learned irrelevance paradigm.
    Orosz AT; Feldon J; Gal G; Simon AE; Cattapan-Ludewig K
    Behav Brain Res; 2008 Nov; 193(1):101-7. PubMed ID: 18555542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corpus callosum size and shape in first-episode affective and schizophrenia-spectrum psychosis.
    Walterfang M; Wood AG; Reutens DC; Wood SJ; Chen J; Velakoulis D; McGorry PD; Pantelis C
    Psychiatry Res; 2009 Jul; 173(1):77-82. PubMed ID: 19447585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered metabolic integrity of corpus callosum among individuals at ultra high risk of schizophrenia and first-episode patients.
    Aydin K; Ucok A; Guler J
    Biol Psychiatry; 2008 Nov; 64(9):750-7. PubMed ID: 18486106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychological functioning and brain structure in schizophrenia.
    Crespo-Facorro B; Barbadillo L; Pelayo-Terán JM; Rodríguez-Sánchez JM
    Int Rev Psychiatry; 2007 Aug; 19(4):325-36. PubMed ID: 17671866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.